Literature DB >> 72620

Acute-phase proteins from the liver and enzymes from myocardial infarction; a quantitative relationship.

S J Smith, G Bos, M R Esseveld, H G Van Eijk, J Gerbrandy.   

Abstract

In 14 patients with acute myocardial infarction (M.I.) not having any other disease, the possible quantitative relationship between enzymes from M.I. and changes in concentration of acute phase reactants coming from the liver were studied. The patients were followed up until 1 1/2 years after M.I. and comparison of baseline-protein values took place using a control group of 18 healthy individuals. Quantitation of protein changes was done by planimetric determination of the area under the concentration curve and by taking peak values. The myocardial infarction was quantitatively estimated by mathematical analysis of the time course of alpha-hydroxybutyrate dehydrogenase (alpha-HBDH) plasma concentrations and by taking peak values. A quantitative relationship with enzymatic infarct size was found for haptoglobin, alpha1-acid glycoprotein, alpha1-antitrypsin, C-reactive protein, fibrinogen and E.S.R. Albumin and transferrin did not show a negative quantitative relationship with enzymatic infarct size. Humoral factors originating from the site of tissue injury and evoking in proportion a positive acute phase reaction by the liver are probably the basis for this observed quantitative relationship.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72620     DOI: 10.1016/0009-8981(77)90415-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  New insights in to the treatment of myocardial infarction.

Authors:  Petr Sarapultsev; Oleg Chupakhin; Alex Sarapultsev; Maxim Rantsev; Larisa Sidorova; Svetlana Medvedeva; Irina Danilova
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

3.  Acute phase response in cerebral infarction.

Authors:  J Syrjänen; A M Teppo; V V Valtonen; M Iivanainen; C P Maury
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

4.  Plasma binding of disopyramide.

Authors:  B M David; B W Madsen; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

5.  [Stress-metabolism after myocardial infarction-demonstrated by means of the behaviour of plasma proteins with short half-life (author's transl)].

Authors:  G Ollenschläger; H Gofferje; L Horbach; H Prestele; K Schultis
Journal:  Klin Wochenschr       Date:  1981-05-04

Review 6.  Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously).

Authors:  Ryuichi Ogawa; Joan M Stachnik; Hirotoshi Echizen
Journal:  Clin Pharmacokinet       Date:  2013-03       Impact factor: 6.447

7.  Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.

Authors:  B M David; K F Ilett; E G Whitford; N S Stenhouse
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

8.  Haptoglobin: A major susceptibility gene for diabetic vascular complications.

Authors:  Tal Szafranek; Stuart Marsh; Andrew P Levy
Journal:  Exp Clin Cardiol       Date:  2002

9.  Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids.

Authors:  E M Ohman; K K Teo; A H Johnson; P B Collins; D G Dowsett; J T Ennis; J H Horgan
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

10.  Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction.

Authors:  C P Maury; K J Tötterman; C G Gref; C Ehnholm
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.